OTCMKTS:IPIX Innovation Pharmaceuticals (IPIX) Stock Price, News & Analysis $0.0008 0.00 (-11.11%) As of 11:37 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartSEC FilingsBuy This Stock About Innovation Pharmaceuticals Stock (OTCMKTS:IPIX) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get IPIX alerts:Sign Up Key Stats Today's Range$0.0008▼$0.000850-Day Range N/A52-Week Range$0.0001▼$0.0187Volume9,300 shsAverage Volume248,485 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Innovation Pharmaceuticals, Inc. is a clinical-stage biotechnology company dedicated to the development of novel antimicrobial compounds and innate defense regulators (IDRs). The company’s research focuses on synthetic peptide mimetics designed to harness and amplify the body’s natural immune response, offering an alternative approach to traditional antibiotics and addressing the growing challenge of drug-resistant bacterial infections. At the core of Innovation Pharmaceuticals’ pipeline is brilacidin, a synthetic host defense peptide mimetic undergoing clinical evaluation for acute bacterial skin and skin structure infections and respiratory indications. Utilizing proprietary chemistry platforms, the company seeks to advance brilacidin and additional IDR candidates through human trials, with the goal of securing strategic partnerships or licensing agreements for late-stage development and commercialization. This strategy underscores its commitment to tackling unmet medical needs in infectious and inflammatory diseases. Headquartered in San Diego, California, Innovation Pharmaceuticals collaborates with contract development and manufacturing organizations, as well as academic research centers across North America. The company is guided by an executive leadership team experienced in biopharmaceutical R&D, regulatory strategy, and alliance management. Through its blend of in-house discovery and external partnerships, Innovation Pharmaceuticals aims to bring innovative anti-infective therapies to patients around the globe.AI Generated. May Contain Errors. Read More Receive IPIX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Innovation Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. IPIX Stock News HeadlinesInnovation, pharma profits won't suffer under Trump prescription drug EO - White HouseMay 12, 2025 | msn.comInnovation Pharma Stock Price, Quotes and Forecasts | OTC:IPIX | BenzingaMay 2, 2025 | benzinga.comMy starkest warning in years Porter Stansberry — founder of one of the world’s largest financial research firms — believes we’re entering a historic economic shift he calls The Final Displacement. Backed by warnings from Nobel Prize winners, this rare event could reshape everything from markets to personal wealth, just as past global displacements toppled empires and created new fortunes. His new investigation reveals why it’s unfolding now, what’s driving it, and how to position yourself on the right side of history.October 24 at 2:00 AM | Porter & Company (Ad)Diaceutics Hosts Webinar on Precision Medicine InnovationNovember 5, 2024 | markets.businessinsider.comInnovation at a price: The hidden costs of antibiotic developmentOctober 16, 2024 | msn.comWaverley Pharma Inc. (WAVE.V) Stock Price, News, Quote & History - Yahoo FinanceSeptember 23, 2024 | finance.yahoo.comQPharma Launches New Website Celebrating 30 Years of Compliance and InnovationJuly 25, 2024 | tmcnet.com'Vital to promote innovation for growth in pharma sector'July 22, 2024 | msn.comSee More Headlines IPIX Stock Analysis - Frequently Asked Questions How have IPIX shares performed this year? Innovation Pharmaceuticals' stock was trading at $0.0001 on January 1st, 2025. Since then, IPIX shares have increased by 700.0% and is now trading at $0.0008. How do I buy shares of Innovation Pharmaceuticals? Shares of IPIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Innovation Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some other companies that Innovation Pharmaceuticals investors own include Green Thumb Industries (GTBIF), Cannabix Technologies (BLOZF), Trulieve Cannabis (TCNNF), NVIDIA (NVDA), Planet 13 (PLNHF), Vaxart (VXRT) and CytoDyn (CYDY). Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Biotechnology Sub-IndustryPharmaceutical Products Current SymbolOTCMKTS:IPIX CIK1355250 Webwww.cellceutix.com Phone(978) 921-4125FaxN/AEmployees4Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report This page (OTCMKTS:IPIX) was last updated on 10/24/2025 by MarketBeat.com Staff From Our PartnersNext opportunity for crypto millionsThe floodgates have opened. Bitcoin and Ethereum ETFs are seeing record-breaking inflows, the biggest since...Crypto 101 Media | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredMelt-up warning Porter Stansberry says this bull market is past the “safe zone” and racing toward an event horizon — and in hi...Porter & Company | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredElon Musk is on the lineElon Musk says November 6 could "affect the future of the world" Get ready for the biggest pivot in corpora...Altimetry | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Innovation Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Innovation Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.